Marks Group Wealth Management Inc Sells 8,094 Shares of UnitedHealth Group Incorporated $UNH

Marks Group Wealth Management Inc reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.9% in the first quarter, Holdings Channel reports. The firm owned 39,870 shares of the healthcare conglomerate’s stock after selling 8,094 shares during the period. UnitedHealth Group accounts for approximately 1.0% of Marks Group Wealth Management Inc’s holdings, making the stock its 17th largest position. Marks Group Wealth Management Inc’s holdings in UnitedHealth Group were worth $10,788,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp boosted its position in UnitedHealth Group by 10.2% in the 1st quarter. Bank of New York Mellon Corp now owns 10,088,271 shares of the healthcare conglomerate’s stock valued at $2,729,785,000 after buying an additional 931,037 shares during the period. Illinois Municipal Retirement Fund raised its stake in shares of UnitedHealth Group by 5.1% during the first quarter. Illinois Municipal Retirement Fund now owns 59,715 shares of the healthcare conglomerate’s stock valued at $16,158,000 after acquiring an additional 2,911 shares in the last quarter. Seros Financial LLC grew its stake in UnitedHealth Group by 9.0% in the first quarter. Seros Financial LLC now owns 810 shares of the healthcare conglomerate’s stock worth $219,000 after purchasing an additional 67 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. raised its position in UnitedHealth Group by 36.1% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 4,245 shares of the healthcare conglomerate’s stock valued at $1,148,000 after purchasing an additional 1,125 shares in the last quarter. Finally, Sanctuary Advisors LLC lifted its holdings in shares of UnitedHealth Group by 12.0% in the 1st quarter. Sanctuary Advisors LLC now owns 183,680 shares of the healthcare conglomerate’s stock worth $49,702,000 after buying an additional 19,712 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the sale, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.28% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Truist raised its price target on UnitedHealth Group to $480 and maintained a buy rating, signaling confidence in further upside ahead of earnings. UnitedHealth Group (NYSE:UNH) Price Target Raised to $480.00 at Truist Financial
• Positive Sentiment: KeyCorp lifted its price target to $475 and kept an overweight rating, adding to the bullish analyst backdrop for UNH. UnitedHealth Group had its price target raised by KeyCorp from $400.00 to $475.00.
• Positive Sentiment: Zacks Research upgraded UnitedHealth to strong-buy and nudged up future EPS estimates, reinforcing expectations that the company can beat earnings again. UnitedHealth Group was upgraded by Zacks Research from hold to strong-buy.
• Positive Sentiment: Analysts have been raising earnings forecasts for UnitedHealth, and several reports argue the company has a strong chance to top Q2 expectations based on its historical surprise record and favorable earnings setup. Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
• Neutral Sentiment: UNH is scheduled to report second-quarter results on July 16, so trading is being driven in part by positioning ahead of the earnings release. UnitedHealth Stock Forecast: Piper Sandler Analyst and Technical Indicators Point to Upside Ahead of Q2 Earnings
• Neutral Sentiment: Technical indicators and some market commentary suggest the stock may have room to move higher after earnings, but this is still contingent on the actual results and outlook. UnitedHealth Reports Earnings Thursday. Here’s How Much Its Stock Is Seen Moving
• Negative Sentiment: Broader managed-care stocks sold off after Elevance Health highlighted margin pressure and weak Medicaid-spending trends, which could weigh on sentiment toward UnitedHealth ahead of its report. Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next

UnitedHealth Group Stock Down 1.8%

Shares of UnitedHealth Group stock opened at $417.33 on Thursday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $434.30. The firm’s 50 day moving average price is $402.80 and its 200-day moving average price is $341.04. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The company has a market cap of $378.99 billion, a P/E ratio of 31.52, a PEG ratio of 1.70 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same period last year, the firm earned $7.20 earnings per share. UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 18.39 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 annualized dividend and a yield of 2.2%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio is currently 70.09%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on UNH shares. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a report on Monday. Cantor Fitzgerald restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $385.00 to $405.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Truist Financial boosted their price objective on shares of UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, TD Cowen increased their target price on UnitedHealth Group from $337.00 to $430.00 and gave the company a “hold” rating in a research report on Tuesday. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $429.50.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.